Unlearn.AI Inc

Unlearn.AI, Inc. develops artificial intelligence solutions for clinical research and drug development. The Company creates AI-generated digital twins to optimize and accelerate clinical trial design and execution, partnering with pharmaceutical and biotechnology firms. Unlearn.AI Inc serves companies conducting clinical trials in Europe and the United States.